- Home
- / MEDINET
MEDINET
Stock Price
¥43
2024-10-29
Market Capitalization
¥10.8 B
2024-10-29
Revenue
¥810.3 M
FY, 2025
MEDINET Summary
Company Summary
- Overview
- MEDINET is a contract development and manufacturing organization (CDMO) focused on the cancer immuno-cell therapy. It offers solutions for the regenerative medicine and cell therapy, from pre-clinical research through to development, manufacturing, and commercial launch.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- Ota City, JP | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
Ota City, Tokyo HQ
Japan
6 Chome Heiwajima
Shinagawa City, Tokyo
Japan
MEDINET Financials
Summary Financials
- Revenue (Q2, 2026)
- ¥232.9M
- Gross profit (Q2, 2026)
- ¥118.0M
- Net income (Q2, 2026)
- (¥212.1M)
- Cash (Q2, 2026)
- ¥2.4B
- EBIT (Q2, 2026)
- (¥179.2M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026